OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
3.060
-0.150 (-4.67%)
At close: Mar 31, 2025, 4:00 PM
3.255
+0.195 (6.36%)
Pre-market: Apr 1, 2025, 4:05 AM EDT
OncoCyte Employees
As of December 31, 2024, OncoCyte had 49 total employees, including 46 full-time and 3 part-time employees. The number of employees increased by 3 or 6.52% compared to the previous year.
Employees
49
Change (1Y)
3
Growth (1Y)
6.52%
Revenue / Employee
$38,388
Profits / Employee
-$1,243,388
Market Cap
87.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
OCX News
- 7 days ago - OncoCyte Corporation (OCX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025 - GlobeNewsWire
- 6 weeks ago - Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - GlobeNewsWire
- 2 months ago - Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer - GlobeNewsWire
- 3 months ago - Oncocyte Expands Market Opportunity for VitaGraft™ Kidney - GlobeNewsWire
- 4 months ago - OncoCyte Corporation (OCX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12 - GlobeNewsWire
- 5 months ago - Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles - GlobeNewsWire